Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001310379-24-000002
Filing Date
2024-11-25
Accepted
2024-11-25 15:37:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4685
  Complete submission text file 0001310379-24-000002.txt   6313
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Subject) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-53409 | Film No.: 241495556
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10850 WILSHIRE BLVD. SUITE 1050 LOS ANGELES CA 90024
Business Address
Weber Mark (Filed by) CIK: 0001310379 (see all company filings)

Type: SCHEDULE 13G